Abstract:Objective To evaluate the efficacy and safety of combizym in cirrhotic patients with dyspepsia.Methods This is a prospective,randomized,controlled clinical study.The cirrhotic patients with two or more following symptoms:upper abdominal pain,epigastria burning sensation,postprandial fullness,early satiety,nausea,vomiting,loss of appetite,belching were enrolled.The range of age was 18 to 70 years old and either gender were included.The exclusion criteria included ALT or AST＞200 U/L,T-BIL＞100 μtmol/L;liver failure;massive ascites or abdominal infection;gastrointestinal disease;gastrointestinal bleeding and hepatic encephalopathy Ⅲ stage or more;and other serious complications.Patients were randomly divided into two groups,the control group with regular treatment (rest,liver protective medicine,complication treatment),the treatment group were treated with combizym tablet(2 tablets tid,with a meal or post meal,for 2 weeks) on the basis of regular treatment.The score of dyspeptic symptoms and the safety were assessed respectively at week 1 and week 2 of the trial.Results A total of 166 cirrhotic patients with dyspepsia were enrolled in the study,124 were males and 42 were females,and the average age was (54.9±8.9)years old.Patients were randomly divided into the control group (n=82) and the treatment group (n=84).The baseline data were compared.After 1 week of treatment,the total score of dyspeptic symptoms in both groups declined,and the score in the treatment group (8.8±2.4) was lower than that in the control group (9.6±2.8),but the difference was not statistically significant (P =0.064).After 2 weeks,the scores in both groups further reduced,and the score in the treatment group (5.4±2.1) was significantly lower than that in the control group (8.8±2.6) (P ＜ 0.001).Moreover,the efficacy of combizym on abdominal pain,burning sensation in the upper abdomen,postprandial fullness,early satiety,nausea,vomiting,loss of appetite and belching symptoms was significantlybetter in the treatment group than that in the control group with the effective rates of 61.1％-95.2％ except the symptom ofvomiting.There was no treatment-related adverse drug reactions during the study.Conclusion Combizym is effectiveand safe in the treatment of cirrhotic patients with dyspeptic symptoms.

Efficacy of pancreatin enteric-coated capsules in the treatment of alcoholic fatty liver in patients with dyspeptic symptoms

Efficacy of panereatin enteric-coated capsules and compound azintamide enteric-coated tablets in treatment of patients with alcoholic fatty liver and dyspepsia

The Effect of Lecithins Coupled Decorin Nanoliposomes on Treatment of Carbon Tetrachloride-Induced Liver Fibrosis

Clinical efficacy of teprenone on 92 patients with ethanol-induced chronic gastritis

Effects of Pancreatin Capsules Versus Multienzyme Tablets in the Treatment of Non-Pancreatic Diseases with Dyspepsia

Efficacy of oryz-aspergillus enzyme and pancreatin in cirrhotic patients with dyspepsia: a randomized, controlled study

Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease

Gastro-protecting Effect of Gefarnate on Chronic Erosive Gastritis with Dyspeptic Symptoms.

Effect of polyene phosphatidylcholine combined with fenofibrate capsules in treatment of nonalcoholic steatohepatitis

Protective Function of Phosphoesterase Complex Enteric-coated Tablets against Alcoholic Fatty Liver Disease

Prevention and Treatment on Alcoholic Fatty Liver by Essentiale

Clinical efficacy of Frey and Beger procedures for chronic pancreatitis

Clinical observation of Bifid Triple Viable capsules treatment of nonalcoholic fatty liver disease

Effectiveness of combined omega-3 polyunsaturated fatty acids with dietary nutrition in patients with non-alcoholic fatty liver disease

Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial

[Efficacy of Compound Digestive Enzyme Tablet for Dyspeptic Symptoms: a Randomized Double-Blind Parallel Controlled Multicenter Clinical Trial in China].

Efficacy Analysis on Combination Use of Endoscopy and Enteral Nutrition in the Treatment of Acute Biliary Pancreatitis in Elderly Patients

Effect of adenosylmethionine in Treatment of Alcoholic cirrhosis

Therapeutic Effect of Bifidobacterium Combined with Early Enteral Nutrition in the Treatment of Severe Acute Pancreatitis: a Pilot Study

THE CLINICAL STUDY OF THE EFFECT OF DANQIHUOGAN CAPSULE ON ALCOHOL-INDUCED LIVER FIBROSIS

Analysis on Clinical Efficacy of Frey Procedure for Chronic Pancreatitis